Fabomotizole
Fabomotizole (pronounced: fa-bo-mo-ti-zole) is an anxiolytic drug that was first synthesized in Russia in the early 2000s. It is also known by its chemical name, 2-phenyl-4,5-dihydro-1H-imidazole.
Etymology
The name "Fabomotizole" is derived from its chemical structure. The "Fabo" part of the name is a reference to the phenyl group in its structure, while "motizole" is a reference to the imidazole group.
Pharmacology
Fabomotizole is classified as a non-benzodiazepine anxiolytic, which means it is used to reduce anxiety without the sedative, hypnotic, and dependence-inducing effects of the benzodiazepine class of drugs. It works by binding to the GABA receptor, the same receptor that benzodiazepines bind to, but it does so in a different way, which is why it does not have the same side effects.
Medical Uses
Fabomotizole is used primarily for the treatment of Generalized Anxiety Disorder (GAD) and Panic Disorder (PD). It has also been used off-label for the treatment of other conditions, such as Insomnia and Post-Traumatic Stress Disorder (PTSD).
Side Effects
Like all drugs, Fabomotizole can have side effects. The most common side effects include dizziness, headache, and nausea. Less common side effects can include changes in mood, changes in sleep patterns, and changes in appetite.
Related Terms
- Anxiolytic
- Non-benzodiazepine
- GABA receptor
- Generalized Anxiety Disorder
- Panic Disorder
- Insomnia
- Post-Traumatic Stress Disorder
External links
- Medical encyclopedia article on Fabomotizole
- Wikipedia's article - Fabomotizole
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski